Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Impact of hospital-acquired pneumonia on the Medicare program.

Baker DL, Giuliano KK, Desmarais M, et al. Impact of hospital-acquired pneumonia on the Medicare program. Infect Control Hosp Epidemiol. 2024;45(3):316-321. doi:10.1017/ice.2023.221.

Save
Print
November 8, 2023
Baker DL, Giuliano KK, Desmarais M, et al. Infect Control Hosp Epidemiol. 2024;45(3):316-321.
View more articles from the same authors.

Hospital-acquired pneumonia (HAP) is one of the most common healthcare-associated infections in the United States. In this case-control retrospective study of Medicare beneficiaries, patients with HAP were 2.8 times more likely to die than patients without HAP. Length of stay and overall cost were also significantly higher in the HAP group. The authors suggest quality improvement efforts like the Keystone ICU project could decrease HAP rates, saving lives and money.

Save
Print
Cite
Citation

Baker DL, Giuliano KK, Desmarais M, et al. Impact of hospital-acquired pneumonia on the Medicare program. Infect Control Hosp Epidemiol. 2024;45(3):316-321. doi:10.1017/ice.2023.221.